Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs.
Clinical studies have shown that circadian patterns influence the pharmacokinetics of certain drugs used in the treatment of different diseases. For such drugs, the bioavailability is influenced by the time of administration. The objective of this study was to investigate differences in the pharmacokinetic patterns between a pulsatile drug delivery system using a pulsatile capsule, an immediate release tablet and a controlled release tablet. Metoprolol was chosen as a model drug because of its high solubility and high permeability pattern throughout the GI tract. The dosage forms were administered to four dogs and the plasma levels were measured using LC-MS/MS. Pharmacokinetic parameters were determined for each dosage form. Fluctuations in the plasma time curves over the observation period indicated that physiological factors like motility have an influence on the drug absorption. The comparison of the plasma time curves of the dosage forms showed that each dosage form caused significant differences in the drug plasma levels. The pulsatile drug delivery capsule caused two defined C(max) values for each dose between 1-1.75 and 2.5-3.5h. Implications for the use of a pulsatile drug delivery device for chronopharmacotherapy are discussed. Pulsatile drug delivery offers a promising way for chronopharmacotherapy if the time of administration and pulse time are adjusted to the circadian pattern.
Löbenberg
Raimar
R
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alta., Canada.
Kim
Jae Seung
JS
Amidon
Gordon L
GL
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics; D000818:Animals; D019540:Area Under Curve; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D002940:Circadian Rhythm / Q000502:physiology; D003692:Delayed-Action Preparations; D004285:Dogs; D004304:Dosage Forms; D005260:Female; D007275:Injections, Intravenous; D008297:Male; D013058:Mass Spectrometry; D008790:Metoprolol / Q000008:administration & dosage / Q000493:pharmacokinetics; D010599:Pharmacokinetics; D012995:Solubility
D000319:Adrenergic beta-Antagonists; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D008790:Metoprolol